Isabela Landsteiner, winner of the #THT2025 Fellows Abstract Award, sits down with Daniel Burkhoff to further elaborate on her research on exercise intolerance in HFpEF. Watch the full video here: www.tctmd.com/videos/tht-2...
🚨New science alert! HM3 LVADs are associated w/hemodynamic related events like RVF.
In this prospective RCT, pts who received a novel RV protection strategy upfront post-LVAD implant had better outcomes & less RVF.
#THT2025
🔗: bit.ly/3CEDDN7
🔥 Science Alert!
REBALANCE-HF assessed permanent ablation of the right greater splanchnic nerve in HFpEF. In this sub-study, the authors found that permanent GSN ablation reduced stressed blood volume, thus reducing RAP & PCWP. #THT2025
🔗 bit.ly/4hXV75Q
Simultaneous with #THT2025 is this 🔥 perspective from Dr. Nir Uriel, Dr. Manreet Kanwar, and Dr. Gabriel Sayer et al on challenges of the current advanced HF fellowship structure, proposing critical care pathways specialized for centers with & without advanced therapies.
bit.ly/4gCTJof
Catch DCRI’s Marat Fudim during tomorrow’s late-breaking session at #THT2025 at 7 a.m., where he will be discussing how GSN ablation reduces estimated stressed blood volume in those with HFpEF, and how it supports the REBALANCE-HF mechanism of action.
#MedSky
Baroreflex activation therapy modulates baroreceptor nerve activity, & has been shown to improve exercise capacity & QoL in HFrEF.
This JCF brief report presents a real-world analysis showing that BAT reduces hospital visits & LoS.
#THT2025
🔗 bit.ly/4aW92Y2
Can echo predict peak VO2? Combining AI and echocardiography-Intriguing concept from Dr. Uriel et al. #THT2025 #CardioSky
New science 🚨!
In this new 🔥#JCFIgnite! Dr. Yogita Rochlani, Dr. Enklajd Marsela, and Dr. Ulrich Jorde discuss the evidence behind the AccuCinch device, the CorCinch-HF trial & the potential & limitations of this novel therapy.
#THT2025
🔗 bit.ly/3CC3WUb
Slides from #THT2025 plus news from
@toddneale.bsky.social and livestreaming. Find all of it on our conference page:
www.tctmd.com/conference/t...
Interesting insights on lymphatic drainage in patients with acute decompensated heart failure. #THT2025
Exciting day 2 -“at #THT2025- use of super-saturated oxygen (SSO2) in anterior myocardial infarction- very promising results on improvement in microvascular circulation and signal for reduction in infarction size/ improvement in EF. #cardiosky #MI
#HCM hypertrophic cardiomyopathy - novel
percutaneous intervention with myotomy - presented at #THT2025 #CardioSky
Percutaneous myotomy for HCM? Exciting percutaneous interventions! #THT2025
Workload-corrected PCWP normalized to body weight (PCWL) is a recently defined hemodynamic metric that may have value in assessment of HFpEF in interatrial shunt device (IASD) studies.
Learn more in our latest Perspectives piece.
#THT2025
bit.ly/3WYAEpH
Come see us at #THT2025 - Booth #16! Learn more about submitting your science for publication in JCF-Intersections, get signed up for the latest HFSA Devices in Heart Failure Meeting news, and pick up some #HFSA2025 swag! @jcardfail.bsky.social
Great debate! Are we in DANGER of over-applying DANGER shock trial or should microaxial flow pumps (Impella CP) be the standard of care for anterior AMI shock and HFrEF? #THT2025 #Impella #cardiogenicshock #cardiosky
#THT2025 #JACCHF LBCT: In patients with #heartfailure & #LVEF >40%, APTURE shunt confirmed acceptable safety profile with improvements in HF symptoms, #QoL, & functional capacity without negatively affecting right & left heart function after 2 years, regardless of PVD www.jacc.org/doi/10.1016/...
This 🔥 new brief report describes a first-in-human feasibility study to evaluate the safety/efficacy of the Reprieve System, a bedside fluid mgmnt device that can
1) measure UO
2) semi-auto titrate IV diuretics
3) titrate saline replacement
#THT2025
🔗 bit.ly/4huGrvq
FASTR trial Reprieve system - compared to optimal medical therapy- significantly more urine output and no apparent worsening of renal function. #tht2025
Interesting concept of coronary sinus - LA shunting from ALT FLOW trial - sustained improvement in KCCQ and functional capacity out to 2 years presented by Dr. Javed Butler #THT2025
Excited to arrive at #THT2025 exploring and engaging in heart failure therapeutics … happening now… late breaker discussion of robotic heart transplant
New Science 🚨!
Seated mPAP reflects hemodynamics during most waking hours.
This 🔥 latest study shows how ambulatory seated mPAP monitoring provides valuable insights into short-term responses to isolated changes in HF medication.
#THT2025
bit.ly/410fc4W
Going to #THT2025? Looking forward to the latest science in heart failure therapeutics and reconnecting with colleagues! I’m still looking to connect w my Medtwitter folks here on Bluesky. @dranulala.bsky.social
#THT2025 is less than a month away! Have you registered yet? Register today for a chance to view the latest data and updates on heart failure treatments. tht2025.crfconferences.com #cardiosky
